Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. [electronic resource]
Producer: 19990831Description: 537-47 p. digitalISSN:- 0002-9440
- Adenocarcinoma -- immunology
- Aged
- Antibodies, Monoclonal
- Culture Media, Conditioned -- pharmacology
- Dose-Response Relationship, Drug
- Female
- Humans
- Immunophenotyping
- Interferon-gamma -- antagonists & inhibitors
- Interleukin-10 -- biosynthesis
- Interleukin-12 -- antagonists & inhibitors
- Killer Cells, Lymphokine-Activated -- immunology
- Male
- Middle Aged
- Pancreatic Ducts -- pathology
- Pancreatic Neoplasms -- immunology
- Reverse Transcriptase Polymerase Chain Reaction
- T-Lymphocytes -- immunology
- Th1 Cells -- immunology
- Th2 Cells -- immunology
- Transforming Growth Factor beta -- biosynthesis
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.